[1]
D. Sanyal, P. Mukhopadhyay, and S. Ghosh, “HYPOKALAEMIA AND COMORBIDITIES ARE COMMON AT INITIAL PRESENTATION IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM”, J ASEAN Fed Endocr Soc, vol. 37, no. 2, p. 20, Oct. 2022.